The present provides a condensed pyridine compound (I) represented by the following formula:
(wherein, R2 represents
ring A represents benzene ring, pyridine ring, thiophene ring or furan ring; and
B represents
its pharmaceutically acceptable salt or hydrates thereof, which is a clinically useful medicament having a serotonin antagonism, in particular, that for treating, ameliorating or preventing spastic paralysis or central muscle relaxants for ameliorating myotonia.